Capture

General Practice

Gordon Royle pradaxa
+Education

New Zealand contributes to trial success for dabigatran reversal

New Zealanders made up about a third of participants when idarucizumab was trialled internationally for reversing anti-coagulation

Read more
By Virginia McMillan
Friday 18 August 2017, 05:21 PM
2 minutes to Read
Back to The newspaper
Subscribe to General Practice

Article archive

Latest news

New mammogram clinic rushed into existence after private provider leaves vacuum

16/04/2021

Nurses want to slip off the doctor yoke for the good of primary healthcare

16/04/2021

Professor decries absence of saliva testing as early-detection app goes on trial

16/04/2021

Coalition of the willing offering health to Parihaka

16/04/2021

Getting a message from lack of action: Non-white women are not important?

16/04/2021

Events

National Rural Health Conference 2021

-
Waikato

New Zealand Primary Healthcare Awards | He Tohu Mauri Ora

Auckland

Australasian Skin Cancer Congress

-

Rotorua GP CME 2021

-
view more events

Latest issue

NZD COVER_ 14042021

14 April 2021

View all issues

Facebook

New Zealand Doctor

Twitter

That's interesting

New diabetes cases linked to COVID-19
Prey-crushing Australian spider establishing in New Zealand
Disgraced South Florida eye doctor receives presidential pardon
More That's Interesting